Skip to main content

CON-TGO91-174 - Sun Pharma ANZ Pty Ltd

Product names
  • AUST R 159343 - LANZOPRAN lansoprazole 30 mg capsule blister pack
Decision Date
Duration
The duration of consent is for the first batch manufactured between 1 September 2020 and 28 February 2021.
Non-compliance with standard

The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.

Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines

Help us improve the Therapeutic Goods Administration site